Stock Events

Guerbet SA 

€39.65
29
+€0+0% Today

Statistics

Day High
39.7
Day Low
39.65
52W High
-
52W Low
-
Volume
154
Avg. Volume
-
Mkt Cap
489.27M
P/E Ratio
0.15
Dividend Yield
1.26%
Dividend
0.5

Upcoming

Dividends

1.26%Dividend Yield
10Y Growth
N/A
5Y Growth
-10.07%
3Y Growth
-10.61%
1Y Growth
N/A

Earnings

24MayExpected
Q3 2021
Q1 2022
Q3 2022
Q4 2022
Q3 2023
Q4 2023
Q1 2024
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0ELV.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. Guerbet SA was incorporated in 1926 and is headquartered in Villepinte, France.
Show more...
CEO
Mr. David Hale
Employees
2920
Country
FR
ISIN
FR0000032526
WKN
000870481

Listings